Description

3-Quinolinecarboxylic Acid, 6-Fluoro-1,4-Dihydro-1-(Methylamino)-7-(4-Methyl-1-Piperazinyl)-4-Oxo-, n-Oxide is a high-purity, complex heterocyclic compound featuring a quinoline core with a fluorine substituent and a methylpiperazinyl group. This compound is a critical advanced pharmaceutical intermediate, valued for its role in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and manufacturers in the pharmaceutical and biotechnology sectors for the development of next-generation therapeutic agents.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel fluoroquinolone antibiotic candidates and other therapeutic molecules.
• Antibacterial Research: Used in R&D for developing new antibacterial agents targeting resistant bacterial strains.
• Chemical Synthesis: Serves as a versatile precursor for creating complex molecular libraries in medicinal chemistry.
• Biochemical Research: Employed in studies investigating enzyme inhibition and receptor binding mechanisms.
• Process Development: Utilized in scaling up and optimizing synthetic routes for API production in pilot and commercial-scale manufacturing.

Basic Information

Item	Details
Product Name	3-Quinolinecarboxylic Acid, 6-Fluoro-1,4-Dihydro-1-(Methylamino)-7-(4-Methyl-1-Piperazinyl)-4-Oxo-, n-Oxide
CAS No.	88569-53-3
Molecular Formula	C16H19FN4O4
Molecular Weight	350.35 g/mol
Synonyms	6-Fluoro-1,4-dihydro-1-(methylamino)-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid N-oxide; Gatifloxacin N-Oxide; AM-1155 N-Oxide; Gatifloxacin Impurity; Gatifloxacin Related Compound N-Oxide; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid N-Oxide (related structure); 3-Quinolinecarboxylic acid, 1,4-dihydro-6-fluoro-1-(methylamino)-7-(4-methyl-1-piperazinyl)-4-oxo-, 1-oxide
EINECS	Contact for details

Quality Control

Our 3-Quinolinecarboxylic Acid derivative is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets exacting standards for pharmaceutical R&D. A Certificate of Analysis (COA) detailing all test results is provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.